Form 144/A - Report of proposed sale of securities: [Amend]
SEC Accession No. 0001971857-24-000859
Filing Date
2024-12-16
Accepted
2024-12-16 15:33:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144/A  
1 primary_doc.xml 144/A 4745
  Complete submission text file 0001971857-24-000859.txt   6134
Mailing Address 125 ELM STREET NEW CANAAN CT 06840
Business Address
Steinhart Richard I (Reporting) CIK: 0001293789 (see all company filings)

Type: 144/A

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144/A | Act: 33 | File No.: 001-38410 | Film No.: 241551620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)